Here’s a retraction from Stem Cells and Development that we’re just now getting around to covering. The paper, “Non-viral reprogramming of skeletal myoblasts with valproic acid for pluripotency,” appeared in June 2012 in a preliminary online form and was written by a group at the University of Cincinnati. As the retraction notice states: Continue reading Retraction for stem cell scientist facing misconduct inquiry
Category: united states
Fernández genetics paper in limbo over data concerns
Ariel Fernández, the protein researcher whose theories of drug design lately have come in for questioning, has lost a paper, at least for the moment.
The article, “Supramolecular Evolution of Protein Organization,” appeared online in Annual Reviews of Genetics prior to print. It lists Fernández’s affiliation as ProWD Sciences, in Madison, Wisc. Not much exists on the web about that company, however, except an under-construction site. (ProWD, by the way, is short for PROtein-Water-Dehydron, Fernández’s area of interest.)
Here’s the notice: Continue reading Fernández genetics paper in limbo over data concerns
Analyze this! Analytical Letters retracts chemistry paper for authorship misdirection
Analytical Letters has retracted a 2011 article by a chemistry researcher at Wright State University in Dayton, Ohio, who seems to have avoided giving credit where credit was due.
The article, “Conducting Polymer Matrix Poly(2,2′-bithiophene) Mercury Metal Incorporation,” was written (so readers were told) by Suzanne Lunsford.
Here’s how the retraction notice explains it: Continue reading Analyze this! Analytical Letters retracts chemistry paper for authorship misdirection
Social work researchers lose paper for misuse of data
Irony alert: If you’re going to publish in the Journal of Human Behavior in the Social Environment, you’d better be able to play well with others.
Not so, it seems, with a certain Darrel Montero. Montero, an associate professor in the School of Social Work at Arizona State University, and his colleagues have lost their 2012 paper in the journal for what appears to be a case of data theft.
As the retraction notice explains:
Continue reading Social work researchers lose paper for misuse of data
Nursing journal pulls Novo Nordisk growth hormone paper over data provenance
The Journal of Pediatric Nursing has retracted a 2013 article (meeting abstract, really) on growth hormone after the drug company that employed the authors cried “take it back.”
The research appears to have been presented at a meeting of the Pediatric Endocrinology Nursing Society, and looked at inefficiency in the use of devices for administering growth hormone. All but one of the authors is listed as working for Novo Nordisk, an international pharmaceutical firm.
Here’s the notice: Continue reading Nursing journal pulls Novo Nordisk growth hormone paper over data provenance
Cardiology researcher faked data in his prizewinning PhD thesis — and NIH, AHA grants: ORI
Nitin Aggarwal, formerly of the Medical College of Wisconsin, faked data in his PhD thesis, grant applications to the NIH and American Heart Association, and in two papers, according to new findings by the Office of Research Integrity.
(The case would have apparently first been published in the Federal Register on October 2, except for the government shutdown.)
Here were their findings: Continue reading Cardiology researcher faked data in his prizewinning PhD thesis — and NIH, AHA grants: ORI
Plant journal withdraws paper — or does it?
The temporary withdrawal of a Molecular Plant paper had us scratching our heads, but the issue seems to be explained by a glitch.
If you click on this version of “Application of the CRISPR–Cas System for Efficient Genome Engineering in Plants” (subscription required), you see this:
This paper has been withdrawn pending a decision by the Editorial Board
But that page also says that the latest version of the paper was published on October 3. Clicking on that version sends you to the paper, which begins: Continue reading Plant journal withdraws paper — or does it?
Stem cell scientist says data in retracted paper “is not falsified or fabricated”
On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has now responded:
SUNY Upstate Medical University’s decision to widely publicize the recent decision by the journal Stem Cells to retract an article from my laboratory is a vindictive and retaliatory campaign to defame my scientific credentials in the press and to my scientific colleagues.
I unequivocally state that the data in all published manuscripts is valid and sound and is not falsified or fabricated. SUNY UMU unilaterally requested a retraction from Stem Cells, despite the fact that the federal Office of Research Integrity (ORI) has not yet ruled on these allegations. It is not surprising that UMU has decided to publicize this retraction in a public forum as a second attempt to force me from my tenured faculty position and circumvent decision of the employment arbitrator and the New York Supreme Court.
To date SUNY UMU has refused to abide by the arbitrator’s “binding” decision to reinstate my faculty position and has failed to pay proper back-wages. The arbitrator evaluated operations of my spin-off company, Humurine Technologies, and stated: Continue reading Stem cell scientist says data in retracted paper “is not falsified or fabricated”
Pamela Ronald does the right thing again, retracting a Science paper
About a month ago, we reported on a retraction by Pamela Ronald, of the University of California, Davis, and colleagues. We noted then that this was a case of scientists doing the right thing. Ronald contacted us after that post ran, and let us know that there would be another retraction shortly. That retraction notice has now appeared, in Science: Continue reading Pamela Ronald does the right thing again, retracting a Science paper
Embryonic stem cell paper retracted for fabrication
Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable.
The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin.
According to the retraction notice: Continue reading Embryonic stem cell paper retracted for fabrication